当前位置: 首页 > 期刊 > 《中国医学创新》 > 2024年第20期
编号:2156173
CT三维重建辅助单孔胸腔镜肺叶切除术在早期非小细胞肺癌患者中的应用观察
http://www.100md.com 2024年7月30日 中国医学创新 2024年第20期
    

    【摘要】 目的:探究CT三维重建辅助单孔胸腔镜肺叶切除术在早期非小细胞肺癌(NSCLC)治疗中的应用效果。方法:回顾性选取2021年1月—2023年12月赣州市肿瘤医院收治的88例早期NSCLC患者作为研究对象,所有患者均行单孔胸腔镜肺叶切除术治疗,根据术前是否行CT三维重建将患者分为重建组(n=37)和非重建组(n=51)。观察重建组术前CT三维重建定位情况,比较两组围手术期指标、术后并发症发生情况。结果:重建组术前CT三维重建定位肺动脉、肺静脉、支气管与术中探查的符合率分别为94.59%、97.30%、100%;肺静脉或肺动脉解剖变异的发生率为18.92%。重建组手术时间、胸腔引流时间及住院时间均短于非重建组,术中出血量、胸腔总引流量均少于非重建组,差异均有统计学意义(P<0.05)。重建组并发症总发生率为13.51%,低于非重建组的33.33%,差异有统计学意义(P<0.05)。结论:CT三维重建辅助单孔胸腔镜肺叶切除术治疗早期NSCLC患者,可缩短手术时间及住院时间,减少出血、胸腔引流量与术后并发症,提高手术安全性与精确性。

    【关键词】 非小细胞肺癌 单孔胸腔镜肺叶切除术 CT三维重建 围手术期指标 并发症

    Application of CT Three-dimensional Reconstruction Assisted Single-aperture Thoracoscopic Lobectomy in Early-stage Non-small Cell Lung Cancer/XIE Baolong, YE Yongqiang, WANG Gang. //Medical Innovation of China, 2024, 21(20): 0-044

    [Abstract] Objective: To explore the application effect of CT three-dimensional reconstruction assisted by single-aperture thoracoscopic pulmonary lobectomy in the treatment of early-stage non-small cell lung cancer (NSCLC). Method: A total of 88 patients with early-stage NSCLC admitted to Ganzhou Cancer Hospital from January 2021 to December 2023 were retrospectively selected as the study objects. All patients underwent single-aperture thoracoscopic lobotomy. The patients were divided into reconstruction group (n=37) and non-reconstruction group (n=51) according to whether CT three-dimensional reconstruction was performed before surgery. Positioning condition of preoperative CT three-dimensional reconstruction was observed in the reconstruction group. Perioperative indexes and postoperative complications were compared between the two groups. Result: In the reconstruction group ......

您现在查看是摘要页,全文长 12277 字符